
Richard Bartens Dewey III MD
Movement Disorder, Neurodegenerative
Movement Disorders Specialist
Join to view full profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Dewey is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Richard Bartens Dewey III was born in Rochester, Minnesota, during his father’s tenure as resident and fellow at the Mayo Clinic in Rochester. Growing up in Dallas, Texas, he began to develop an interest in Parkinson’s Disease while working with his father’s patients researching the correlation of symptom onset and disease progression.
After undergraduate training in California, Dr. Dewey completed medical school, residency, and fellowship training at UT Southwestern in 2022, specializing in Movement Disorders.
He began practicing in Boca Raton, Florida, as an investigator in over 50 different research trials exploring pharmaceutical treatments for a wide array of movement disorders. He joined the Mayo Clinic in Florida in 2026.
Dr. Dewey's primary research and clinical interests include neuroprotection and management of early Parkinson’s Disease, mitigation of non-motor symptoms of Parkinson’s Disease, and novel therapeutic approaches to Essential Tremor. He is experienced in deep brain stimulation programming as well as botulinum toxin injections for many neurologic conditions. Dr. Dewey has authored both scientific abstracts and peer-reviewed publications in journals such as Cognitive and Behavioral Neurology, Parkinson’s Disease, PLOS ONE, and The Journal of the Neurological Sciences.
Education & Training
University of Texas Southwestern Medical CenterResidency, Neurology, 2017 - 2021
University of Texas Southwestern Medical SchoolClass of 2017
Certifications & Licensure
FL State Medical License 2022 - 2028
TX State Medical License 2019 - 2027
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin Start of enrollment: 2021 Nov 04
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsApomorphine titration with and without anti-emetic pretreatment in patients with Parkinson's disease experiencing OFF episodes: A modified Delphi panel.Stuart H Isaacson, Richard Dewey, Robert A Hauser, Daniel Kremens, Rajeev Kumar
Clinical Parkinsonism & Related Disorders. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









